BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 37326116)

  • 1. Lifestyle Modulators of Neuroplasticity in Parkinson's Disease: Evidence in Human Neuroimaging Studies.
    Paola Caminiti S; Gallo S; Menegon F; Naldi A; Comi C; Tondo G
    CNS Neurol Disord Drug Targets; 2024; 23(5):602-613. PubMed ID: 37326116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Narrative Review of Lifestyle Factors Associated with Parkinson's Disease Risk and Progression.
    Nag N; Jelinek GA
    Neurodegener Dis; 2019; 19(2):51-59. PubMed ID: 31487721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management.
    Wal P; Vig H; Wal A; Rathore S; Pandey SS; Jain NK; Srivastava A
    Curr Aging Sci; 2023; 16(3):170-187. PubMed ID: 37638586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise and Parkinson's Disease.
    Bonavita S
    Adv Exp Med Biol; 2020; 1228():289-301. PubMed ID: 32342465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced neuroplasticity in human Parkinson's disease: What is the evidence telling us?
    Hirsch MA; Iyer SS; Sanjak M
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S78-81. PubMed ID: 26439945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?
    Hanganu A; Monchi O
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):91. PubMed ID: 30324260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle Modulators of Neuroplasticity: How Physical Activity, Mental Engagement, and Diet Promote Cognitive Health during Aging.
    Phillips C
    Neural Plast; 2017; 2017():3589271. PubMed ID: 28695017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural MRI in Idiopathic Parkinson's Disease.
    De Micco R; Russo A; Tessitore A
    Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging in pre-motor Parkinson's disease.
    Barber TR; Klein JC; Mackay CE; Hu MTM
    Neuroimage Clin; 2017; 15():215-227. PubMed ID: 28529878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
    Dean DC; Sojkova J; Hurley S; Kecskemeti S; Okonkwo O; Bendlin BB; Theisen F; Johnson SC; Alexander AL; Gallagher CL
    PLoS One; 2016; 11(10):e0163774. PubMed ID: 27706215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
    Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
    Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroplasticity mediated by motor rehabilitation in Parkinson's disease: a systematic review on structural and functional MRI markers.
    Baglio F; Pirastru A; Bergsland N; Cazzoli M; Tavazzi E
    Rev Neurosci; 2022 Feb; 33(2):213-226. PubMed ID: 34461010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral biomarkers in exercise-induced neuroplasticity in Parkinson's disease.
    Mougeot JL; Hirsch MA; Stevens CB; Mougeot F
    Oral Dis; 2016 Nov; 22(8):745-753. PubMed ID: 26878123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and neuroplasticity in persons living with Parkinson's disease.
    Hirsch MA; Farley BG
    Eur J Phys Rehabil Med; 2009 Jun; 45(2):215-29. PubMed ID: 19532109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-Induced Neuroplasticity in Parkinson's Disease: A Metasynthesis of the Literature.
    Johansson H; Hagströmer M; Grooten WJA; Franzén E
    Neural Plast; 2020; 2020():8961493. PubMed ID: 32256559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle Interventions for the Prevention of Parkinson Disease: A Recipe for Action.
    Janssen Daalen JM; Schootemeijer S; Richard E; Darweesh SKL; Bloem BR
    Neurology; 2022 Aug; 99(7 Suppl 1):42-51. PubMed ID: 35970584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease.
    Wen MC; Chan LL; Tan LCS; Tan EK
    Acta Neurol Scand; 2017 Aug; 136(2):84-96. PubMed ID: 28670700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
    Christopher L; Strafella AP
    J Neuropsychol; 2013 Sep; 7(2):225-40. PubMed ID: 23551844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.